Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells

Authors:

Abstract
Inflammation is a key event in the development of atherosclerosis. Nuclear factor-κB (NF-κB) is important in the inflammatory response regulation. The effector peptide of the renin angiotensin system Angiotensin II (Ang II) activates NF-κB and upregulates some related proinflammatory genes. Our aim was to investigate whether other angiotensin-related peptides, as the N-terminal degradation peptide Ang IV, could regulate proinflammatory factors (activation of NF-κB and related genes) in cultured vascular smooth muscle cells (VSMCs). In these cells, Ang IV increased NF-κB DNA binding activity, caused nuclear translocation of p50/p65 subunits, cytosolic IκB degradation and induced NF-κB–dependent gene transcription. Ang II activates NF-κB via AT 1 and AT 2 receptors, but AT 1 or AT 2 antagonists did not inhibit NF-κB activation caused by Ang IV. In VSMC from AT 1a receptor knockout mice, Ang IV also activated NF-κB pathway. In those cells, the AT 4 antagonist divalinal diminished dose-dependently Ang IV–induced NF-κB activation and prevented IκB degradation, but had no effect on the Ang II response, indicating that Ang IV activates the NF-κB pathway via AT 4 receptors. Ang IV also increased the expression of proinflammatory factors under NF-κB control, such as MCP-1, IL-6, TNF-α, ICAM-1, and PAI-1, which were blocked by the AT 4 antagonist. Our results reveal that Ang IV, via AT 4 receptors, activates NF-κB pathway and increases proinflammatory genes. These data indicate that Ang IV possesses proinflammatory properties, suggesting that this Ang degradation peptide could participate in the pathogenesis of cardiovascular diseases.

This publication has 40 references indexed in Scilit: